Home › Trial NCT00711191
A Study On An Immunostimulant Antibody In Combination With Chemotherapy For Advanced Cancer Of The Pancreas
- Trial IDNCT00711191
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorHoffmann-La Roche
- Enrollment22
- Start date2008-06
- ConditionsPancreatic Neoplasm
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.